Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cytosorbents Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 50 | 50 | 0 |
| Shares | 17.6M | 16.7M | −929.7K (−5.3%) |
| Value | $16.7M | $11.8M | −$4.92M (−29.5%) |
New holders (3)
Institutions that held Cytosorbents Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EP Wealth Advisors, LLC | 28,000 | $19.7K | 0.00% |
| Redwood Wealth Management Group, LLC | 8,200 | $5.76K | 0.00% |
| FMR LLC | 285 | $200 | 0.00% |
Sold out (3)
Institutions that held Cytosorbents Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Regal Investment Advisors LLC | 11,509 | $10.9K |
| Bank of New York Mellon Corp | 3,640 | $3.46K |
| Lazard Asset Management LLC | 1,090 | $1.00K |